Venus gets marketing nod from Venezuela

Capital Market

Last Updated : Apr 04 2014 | 12:05 AM IST

For meropenem

Venus Remedies has received marketing authorisation for meropenem from Venezuela, a $6 billion pharmaceutical market. The Company plans to lauch meropenem in Venezuela in the next couple of months.

Powered by Capital Market - Live News

More From This Section

HCL Technologies allots equity shares

Outcome of board meeting of Navkar Builders

Board of Tribhuvan Housing appoints director

GM Breweries to hold AGM

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 03 2014 | 6:08 PM IST

Explore News

Stock Market LIVE Updates Stocks to Watch Today RBI MPC Meeting Small Midcap Stocks Stocks to Buy Today SBI Q3 Results Preview LIC Q3 Result UK PM Apologises to Epstein Victims Gold and Silver Price Today Q3 Results Today